Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic?
Sanders
S P
SP
Department of Medicine, Division of Pulmonary and Critical Care Medicine, The Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA. ssanders@welch.jhu.edu
D000818:Animals; D001249:Asthma / Q000175:diagnosis* / Q000209:etiology* / Q000378:metabolism / Q000628:therapy*; D001980:Bronchi / Q000201:enzymology; D006801:Humans; D008168:Lung / Q000201:enzymology; D051379:Mice; D018345:Mice, Knockout; D009569:Nitric Oxide / Q000378:metabolism / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000378:metabolism / Q000633:toxicity; D052247:Nitric Oxide Synthase Type II
D009569:Nitric Oxide; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse